Dr. Reddy’s Generic Ozempic Supplies Delayed on API Issue

Dr. Reddy’s Laboratories Ltd. will delay the commercial production of its generic Ozempic drug after it found an unspecified issue with the active pharmaceutical ingredient in some batches of the anti-obesity and diabetes therapy.